BioNTech

BioNTech SE American Depositary Share is the U.S.-traded depositary share of BioNTech SE, a Germany-based biotechnology company focused on immunotherapy and vaccines. The company develops cancer therapeutics, including individualized treatment approaches such as personalized immunotherapies, and also works on vaccines for infectious diseases. Its research and development activities span multiple platforms, including mRNA-based products, cell therapies, and other next-generation immune-modulating technologies. BioNTech serves global healthcare and life-science markets through a portfolio centered on oncology and infectious-disease prevention. The American Depositary Share structure allows U.S. investors to trade BioNTech’s ordinary share interest in a familiar market format, while the underlying business remains concentrated on advancing medical research, clinical development, and commercialized biotechnology products.